US Patent Issued to Memorial Sloan Kettering Cancer Center on Dec. 16 for "Compositions and methods for adoptive cell therapy" (New York Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,310, issued on Dec. 16, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Compositions and methods for adoptive cell therapy" was invented by David A. Scheinberg (New York), Thomas J. Gardner (New York), Derek S. Tan (New York) and Jonghan Lee (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express an antigen-targeted chimeric antigen receptor and a prodrug converting enzyme for the treatment of inflammation, inflammatory diseases, or pathogenic infections."

The patent was filed on July 2, 2018, under Application...